OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals' mission is to translate its founders' cancerous stem cell insights into novel medicines capable of eliminating the cancer stem cell and halting the spread of solid tumors. The company has identified about 50 proteins characteristic of cancer stem cells and has established a large library of antibodies capable of binding to them. It is also identifying small-molecule compounds that can halt these cancer stem cells.